CorriXR Therapeutics
Wilmington, US · 1 known investors
Corrixr Therapeutics is developing targeted genetic medicine for treatment-resistant cancers, with a focus on advancing its CXR101 therapeutic candidate through clinical development and translational research.
BiotechMedical Devices
Founders & leadership
EB
Eric B. KmiecFounder & Chief Scientific Officer
Investors · 1
In the news
- Medpathtrial.medpath.com · 2025
- CorriXR Therapeutics Receives $1M Investment from State of Delawarefinsmes.com · 2025
- CorriXR Therapeutics - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2022